SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX)

Abstract

Episodes of ocular hypertension after Ozurdex implant were generally transient and successfully managed with topical treatment. An analysis of the risk factors may help to determine the risk-benefit ratio for individual patients treated with dexamethasone implants.